Overview
Maris Sperga practices in Riga, Latvia. Sperga is rated as an Experienced expert by MediFind in the treatment of Pancreatic Islet Cell Tumor. Their top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Renal Cell Carcinoma (RCC), and Uterine Fibroids.
Their clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Pancreatic Islet Cell Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaSperga isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Renal OncocytomaSperga isDistinguished. Learn about Renal Oncocytoma.
- Advanced
- Renal Cell Carcinoma (RCC)
- Experienced
- Actinic KeratosisSperga isExperienced. Learn about Actinic Keratosis.
- Anal CancerSperga isExperienced. Learn about Anal Cancer.
- InsulinomaSperga isExperienced. Learn about Insulinoma.
- Neuroendocrine TumorSperga isExperienced. Learn about Neuroendocrine Tumor.
- Pancreatic CancerSperga isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Islet Cell TumorSperga isExperienced. Learn about Pancreatic Islet Cell Tumor.